Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Respir Med ; 186: 106531, 2021 09.
Article in English | MEDLINE | ID: mdl-34260977

ABSTRACT

The covid-19 pandemic has been affecting many countries across the world and lost precious lives. Most patients suffer from respiratory disease which progresses to the severe acute respiratory syndrome, termed as SARS-CoV-2 pneumonia. A systemic inflammatory response occurs in SARS-CoV-2 pneumonia severely ill patients, The inflammation process if uncontrolled has a detrimental effect, and the release of cytokines play an important role leading to lung fibrosis. Radiation therapy used in low doses has an anti-inflammatory and immunomodulatory effect. Its low cost, wider availability, and decreased risk of acute side effects can reduce the burden on the health care system.


Subject(s)
COVID-19/radiotherapy , Radiotherapy/methods , Severe Acute Respiratory Syndrome/radiotherapy , COVID-19/complications , COVID-19/virology , Cytokines/metabolism , Disease Progression , Humans , Inflammation , Inflammation Mediators/metabolism , Macrophages , Pulmonary Fibrosis/etiology , Pulmonary Fibrosis/radiotherapy , Radiotherapy Dosage , SARS-CoV-2 , Severe Acute Respiratory Syndrome/etiology , Severity of Illness Index
2.
Radiat Oncol ; 12(1): 172, 2017 Nov 07.
Article in English | MEDLINE | ID: mdl-29116014

ABSTRACT

BACKGROUND: Normal lung tissue tolerance constitutes a limiting factor in delivering the required dose of radiotherapy to cure thoracic and chest wall malignancies. Radiation-induced lung fibrosis (RILF) is considered a critical determinant for late normal tissue complications. While RILF mouse models are frequently approached e.g., as a single high dose thoracic irradiation to investigate lung fibrosis and candidate modulators, a systematic radiobiological characterization of RILF mouse model is urgently needed to compare relative biological effectiveness (RBE) of particle irradiation with protons, helium-, carbon and oxygen ions now available at HIT. We aimed to study the dose-response relationship and fractionation effect of photon irradiation in development of pulmonary fibrosis in C57BL/6 mouse. METHODS: Lung fibrosis was evaluated 24 weeks after single and fractionated whole thoracic irradiation by quantitative assessment of lung alterations using CT. The fibrosis index (FI) was determined based on 3D-segmentation of the lungs considering the two key fibrosis parameters affected by ionizing radiation i.e., a dose/fractionation dependent reduction of the total lung volume and increase of the mean lung density. RESULTS: The effective dose required to induce 50% of the maximal possible fibrosis (ED 50 ) was 14.55 ± 0.34Gy and 27.7 ± 1.22Gy, for single and five- fractions irradiation, respectively. Applying a deterministic model an α/ß = 4.49 ± 0.38 Gy for the late lung radiosensitivity was determined. Intriguingly, we found that a linear-quadratic model could be applied to in-vivo log transformed fibrosis (FI) vs. irradiation doses. The LQ model revealed an α/ß for lung radiosensitivity of 4.4879 Gy for single fraction and 3.9474 for 5-fractions. Our FI based data were in good agreement with a meta-analysis of previous lung radiosensitivity data derived from different clinical endpoints and various mouse strains. The effect of fractionation on RILF development was further estimated by the biologically effective dose (BED) model with threshold BED (BED Tr ) = 30.33 Gy and BED ED50  = 61.63 Gy, respectively. CONCLUSION: The systematic radiobiological characterization of RILF in the C57BL/6 mouse reported in this study marks an important step towards precise estimation of dose-response for development of lung fibrosis. These radiobiological parameters combined with a large repertoire of genetically engineered C57BL/6 mouse models, build a solid foundation for further biologically individualized risk assessment of RILF and functional RBE prediction on novel of particle qualities.


Subject(s)
Pulmonary Fibrosis/physiopathology , Pulmonary Fibrosis/radiotherapy , Radiotherapy Dosage , Animals , Carbon/chemistry , Disease Models, Animal , Dose Fractionation, Radiation , Dose-Response Relationship, Radiation , Female , Ions/chemistry , Linear Models , Male , Mice , Mice, Inbred C57BL , Oxygen/chemistry , Photons , Radiation Pneumonitis/physiopathology , Radiation Tolerance , Relative Biological Effectiveness , Thoracic Neoplasms/radiotherapy , Thoracic Wall/radiation effects , Tomography, X-Ray Computed
3.
Lasers Med Sci ; 32(8): 1825-1834, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28712048

ABSTRACT

Lung fibrosis (LF) is a chronic and progressive lung disease characterized by pulmonary parenchyma progressive lesion, inflammatory infiltration, and interstitial fibrosis. It is developed by excessive collagen deposition and other cellular matrix components, resulting in severe changes in the alveolar architecture. Considering the absence of effective treatment, the aim of this study was to investigate the effect of photobiomodulation therapy (PBMT) on the development of PF. For this purpose, we used C57BL6 mice subjected to induction of LF by bleomycin administration (1.5 U/kg) by orotracheal route and, after 14 days of the induction, mice were treated with PBMT applied to the thorax 1×/day for 8 days (wavelength 660 ± 20 nm, power 100 mW, radiant exposure 5 J/cm2, irradiance 33.3 mW/cm2, spot size 2.8cm2, total energy 15 J, time of irradiation: 150 s) and inflammatory and fibrotic parameters were evaluated with or without PBMT. Our results showed that PBMT significantly reduced the number of inflammatory cells in the alveolar space, collagen production, interstitial thickening, and static and dynamic pulmonary elastance. In addition, we observed reduced levels of IL-6 e CXCL1/KC released by pneumocytes in culture as well as reduced level of CXCL1/KC released by fibroblasts in culture. We can conclude that the PBMT improves both inflammatory and fibrotic parameters showing a promising therapy which is economical and has no side effects.


Subject(s)
Inflammation/pathology , Low-Level Light Therapy/methods , Pulmonary Fibrosis/radiotherapy , Alveolar Epithelial Cells/metabolism , Alveolar Epithelial Cells/radiation effects , Animals , Bleomycin , Bronchoalveolar Lavage , Chemokine CXCL1/metabolism , Collagen/biosynthesis , Disease Models, Animal , Fibroblasts/metabolism , Fibroblasts/radiation effects , Inflammation/complications , Interferon-gamma/metabolism , Interleukin-6/metabolism , Lung/pathology , Lung/radiation effects , Male , Mice, Inbred C57BL
4.
PLoS One ; 11(5): e0154942, 2016.
Article in English | MEDLINE | ID: mdl-27171163

ABSTRACT

Radiation-induced lung fibrosis, the most serious effect of lung cancer radiotherapy on normal tissue, remains a major technical obstacle to the broader application of radiotherapy to patients with lung cancer. This study describes the use of an image-guided irradiation system in mice mimicking stereotactic body radiotherapy (SBRT) to examine the molecular features of chronic fibrotic response after radiation injury. MicroRNA (miR) array analysis of injured pulmonary tissue identified a set of miRs whose expression was significantly increased in damaged lung tissue. In particular, miR-21 expression was increased at the radiation injury site, concurrent with collagen deposition. Although the inhibition of miR-21 by its specific inhibitor anti-miR-21 only marginally affected endothelial-mesenchymal transition (EndMT) in lung endothelial cells, this inhibition significantly reduced collagen synthesis in lung fibroblasts. Furthermore, ectopic expression of miR-21 was sufficient to promote a fibrotic response in lung fibroblasts, enhancing Smad2 phosphorylation concurrent with Smad7 downregulation. These findings indicate that the induction of miR-21 expression is responsible for fibrotic responses observed in mesenchymal cells at the injury site through the potentiation of TGF-ß signaling. Local targeting of miR-21 at the injured area could have potential therapeutic utility in mitigating radiation-induced lung fibrosis.


Subject(s)
MicroRNAs/genetics , Pulmonary Fibrosis/genetics , Pulmonary Fibrosis/radiotherapy , Radiosurgery , Animals , Cell Line , Collagen/biosynthesis , Endothelial Cells/metabolism , Endothelial Cells/pathology , Endothelium/pathology , Fibroblasts/metabolism , Fibroblasts/pathology , Humans , Lung/metabolism , Lung/pathology , Lung/radiation effects , Male , Mesoderm/pathology , Mice, Inbred C57BL , MicroRNAs/metabolism , Pulmonary Fibrosis/pathology , Radiation, Ionizing , Transfection , Up-Regulation/genetics
5.
Cancer Res ; 76(10): 3045-56, 2016 05 15.
Article in English | MEDLINE | ID: mdl-26921334

ABSTRACT

Radiation-induced pulmonary fibrosis is a severe side effect of thoracic irradiation, but its pathogenesis remains poorly understood and no effective treatment is available. In this study, we investigated the role of the extracellular adenosine as generated by the ecto-5'-nucleotidase CD73 in fibrosis development after thoracic irradiation. Exposure of wild-type C57BL/6 mice to a single dose (15 Gray) of whole thorax irradiation triggered a progressive increase in CD73 activity in the lung between 3 and 30 weeks postirradiation. In parallel, adenosine levels in bronchoalveolar lavage fluid (BALF) were increased by approximately 3-fold. Histologic evidence of lung fibrosis was observed by 25 weeks after irradiation. Conversely, CD73-deficient mice failed to accumulate adenosine in BALF and exhibited significantly less radiation-induced lung fibrosis (P < 0.010). Furthermore, treatment of wild-type mice with pegylated adenosine deaminase or CD73 antibodies also significantly reduced radiation-induced lung fibrosis. Taken together, our findings demonstrate that CD73 potentiates radiation-induced lung fibrosis, suggesting that existing pharmacologic strategies for modulating adenosine may be effective in limiting lung toxicities associated with the treatment of thoracic malignancies. Cancer Res; 76(10); 3045-56. ©2016 AACR.


Subject(s)
5'-Nucleotidase/physiology , Adenosine/metabolism , Disease Models, Animal , Pulmonary Fibrosis/pathology , Radiation, Ionizing , Animals , Apoptosis , Blotting, Western , Cell Proliferation , GPI-Linked Proteins/physiology , Humans , Immunoenzyme Techniques , Mice , Mice, Inbred C57BL , Mice, Knockout , Pulmonary Fibrosis/metabolism , Pulmonary Fibrosis/radiotherapy , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Tumor Cells, Cultured , Xenograft Model Antitumor Assays
7.
South Med J ; 101(10): 1056-8, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18791523

ABSTRACT

Fibrosing mediastinitis with bronchial artery hypervascularity is a rare cause of massive hemoptysis. Conventional therapies for massive hemoptysis include pulmonary or bronchial artery embolization, endobronchial tamponade, or lung resection. A patient with fibrosing mediastinitis presented with refractory massive hemoptysis associated with bronchial hypervascularity and was treated with external-beam radiotherapy (XRT). The application of XRT for massive hemoptysis in malignant and nonmalignant disease of the thorax is discussed.


Subject(s)
Hemoptysis/radiotherapy , Mediastinitis/radiotherapy , Pulmonary Fibrosis/radiotherapy , Hemoptysis/etiology , Humans , Male , Mediastinitis/complications , Middle Aged , Pulmonary Fibrosis/complications
8.
Cancer Res ; 67(22): 10796-803, 2007 Nov 15.
Article in English | MEDLINE | ID: mdl-18006824

ABSTRACT

Thoracic radiotherapy may produce the morbidity-associated lung responses of alveolitis or fibrosing alveolitis in treated cancer patients. The genetic factors that influence a patient's likelihood of developing alveolitis and the relationship of this inflammatory response to the development of fibrosis are largely unknown. Herein we use genetic mapping to identify radiation-induced lung response susceptibility loci in reciprocal backcross mice bred from C3H/HeJ (alveolitis response) and C57BL/6J (fibrosing alveolitis/fibrosis response) strains. Mice were treated with 18-Gy whole thorax irradiation and their survival, lung histopathology, and bronchoalveolar lavage cell types were recorded. A genome-wide scan was completed using 139 markers. The C3H/HeJ alveolitis response included mast cell infiltration and increased neutrophil numbers in the lavage compared with the level in the C57BL/6J strain, which developed fibrosis. In backcross mice, posttreatment survival was dictated by the development of an alveolitis response with increased mast cell, bronchoalveolar lavage total cell, and neutrophil numbers. Fibrosis was measured only in a subset of mice developing alveolitis and, in these mice, was associated with neutrophil count. Genotyping revealed coinheritance of C3H alleles (chromosomes 2, 4, 19, and X) and C57BL/6J alleles (chromosomes 1, 7, 9, and 17) to result in higher fibrosis scores in backcross mice. Mice that inherited C57BL/6J alleles at the putative alveolitis susceptibility loci were spared this response and lived to the end of the experiment. In this animal model, independent loci control the development of alveolitis from fibrosis, whereas fibrosing alveolitis occurs with the coinheritance of these factors.


Subject(s)
Pulmonary Fibrosis/pathology , Pulmonary Fibrosis/radiotherapy , Alleles , Animals , Bronchoalveolar Lavage , Crosses, Genetic , Genome , Genotype , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Neutrophils/metabolism , Phenotype , Radiotherapy/methods , Species Specificity
9.
Bone Marrow Transplant ; 31(10): 939-41, 2003 May.
Article in English | MEDLINE | ID: mdl-12748674

ABSTRACT

Delayed pulmonary toxicity syndrome, characterized by interstitial pneumonia and pulmonary fibrosis, is common following high-dose bischloroethylnitrosourea (BCNU) (carmustine, [1,3-bis (2-chloroethyl)-1-nitrosourea]) containing chemotherapeutic regimens. Depending upon the treatment protocol, it may develop in over 70% of patients. Early and aggressive corticosteroid treatment leads to improvement in the majority of patients. However, up to 8% of affected patients may fail to respond to corticosteroids and develop progressive respiratory failure leading to death. No alternatives to corticosteroids have thus far been shown useful. We report the symptomatic and physiological improvement of a patient with severe steroid-resistant delayed pulmonary toxicity syndrome, following treatment with interferon-gamma.


Subject(s)
Adrenal Cortex Hormones/adverse effects , Breast Neoplasms/drug therapy , Carmustine/adverse effects , Interferon-gamma/therapeutic use , Lung/drug effects , Lung/pathology , Pulmonary Fibrosis/chemically induced , Antineoplastic Agents, Alkylating/adverse effects , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Breast Neoplasms/radiotherapy , Female , Humans , Middle Aged , Pulmonary Fibrosis/radiotherapy , Respiratory Function Tests , Syndrome , Time Factors , Treatment Outcome
10.
Chest ; 100(4): 1164-5, 1991 Oct.
Article in English | MEDLINE | ID: mdl-1914583

ABSTRACT

The most effective treatment of severe paraquat poisoning in man is uncertain. In order to prevent pulmonary fibrosis, we employed radiotherapy of both lungs in a 23-year-old patient with severe paraquat poisoning; however, it failed to prevent the fatal outcome.


Subject(s)
Paraquat/poisoning , Pulmonary Fibrosis/chemically induced , Pulmonary Fibrosis/radiotherapy , Adult , Humans , Lung/drug effects , Male
11.
Adv Exp Med Biol ; 258: 287-302, 1989.
Article in English | MEDLINE | ID: mdl-2516709

ABSTRACT

Serum copper (Cu) concentration was evaluated as an index of lung injury in two rat models of pneumotoxicity: hemithoracic irradiation and monocrotaline ingestion. In both models there was a dose- and time-dependent increase in serum Cu concentration. This hypercupremia paralleled the development of pulmonary endothelial dysfunction (decreased lung plasminogen activator activity and increased prostacyclin production) and pulmonary fibrosis (hydroxyproline accumulation). In the radiation model, lung injury and hypercupremia persisted for at least 6 months, and were spared similarly when the total dose was delivered in multiple daily fractions as compared to single doses. In irradiated rats, the elevated serum Cu concentration was accompanied by increases in plasma ceruloplasmin, lung Cu concentration, and lung Cu/Zn superoxide dismutase (SOD) activity. In monocrotaline-treated rats, lung damage and hypercupremia also were accompanied by a reduction in liver Cu concentration, and by a direct correlation between the concentrations of Cu and SGOT in the serum. In both models, some but not all modifiers of lung damage (penicillamine, angiotensin converting enzyme inhibitors, pentoxifylline) also partially prevented the insult-induced hypercupremia. In contrast, serum iron concentration was largely independent of treatment in all experiments. These data suggest that elevated serum copper concentration is an accurate and minimally invasive index of lung injury in irradiated and monocrotaline-treated rats.


Subject(s)
Copper/blood , Lung Diseases/blood , Lung Diseases/metabolism , Metal Metabolism, Inborn Errors/metabolism , Alanine Transaminase/metabolism , Animals , Dose-Response Relationship, Radiation , Epoprostenol/biosynthesis , Health Status Indicators , Lung Diseases/complications , Lung Diseases/etiology , Lung Diseases/radiotherapy , Male , Metal Metabolism, Inborn Errors/complications , Metal Metabolism, Inborn Errors/radiotherapy , Pulmonary Fibrosis/complications , Pulmonary Fibrosis/metabolism , Pulmonary Fibrosis/radiotherapy , Rats , Rats, Inbred Strains , Superoxide Dismutase/metabolism
12.
Ann Fr Anesth Reanim ; 7(2): 159-61, 1988.
Article in French | MEDLINE | ID: mdl-3364814

ABSTRACT

A case is reported of severe interstitial paraquat poisoning in a 23 year old man. Initial treatment consisted of gastric lavage, fuller's earth, haemoperfusion on activated charcoal and peritoneal dialysis. On the third day, appeared both renal and early respiratory failure, with hypocapnia and hypoxia. Peritoneal dialysis was kept up to the thirteenth day. Pulmonary function tests showed a restrictive syndrome. Chemotherapy with 1 mg.kg-1.24 h-1 prednisone and 3 mg.kg-1.24 h-1 cyclophosphamide was started on day 4. Radiotherapy (13 Gy) was also given to both lung fields between days 6 and 10. Despite this treatment, respiratory failure worsened, and the patient died at the 28th day, with resistant severe hypoxaemia and pneumothorax on fibrous lungs. Several reports have shown conflicting results with chemotherapy and radiotherapy in the treatment of pulmonary fibrosis due to paraquat poisoning. The failure of such treatment in the case reported showed the need for large prospective clinical trials of the treatment of paraquat poisoning, as well as for urgent preventive measures.


Subject(s)
Paraquat/poisoning , Pulmonary Fibrosis/chemically induced , Adult , Humans , Hypoxia/chemically induced , Male , Paraquat/pharmacokinetics , Pulmonary Fibrosis/drug therapy , Pulmonary Fibrosis/radiotherapy , Respiratory Function Tests
13.
Jpn J Med ; 26(3): 385-7, 1987 Aug.
Article in English | MEDLINE | ID: mdl-3694922

ABSTRACT

A 51-year-old man was admitted 3 hours after ingesting approximately 50 ml of mixture of paraquat and organophosphate insecticide. His arterial oxygen pressure fell progressively to 44.6 mmHg. Diagnosed was paraquat-induced interstitial pneumonia. No improvement was observed after treatment with corticosteroid. The pneumonia, however, resolved after irradiation of both lungs and arterial oxygen pressure showed marked improvement. Radiotherapy to the lungs should be considered only in patients who showed progressive deterioration of respiratory function.


Subject(s)
Paraquat/poisoning , Pulmonary Fibrosis/radiotherapy , Combined Modality Therapy , Humans , Male , Methylprednisolone/therapeutic use , Middle Aged , Pulmonary Fibrosis/chemically induced , Pulmonary Fibrosis/drug therapy , Radiation Dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...